University of Zurich: Communicable Diseases trials

The registry lists 10 Communicable Diseases studies with University of Zurich as lead sponsor. 3 are open to participants now and 2 have results posted.

Early Phase 1 1Phase 2 1Phase 4 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Breath Analysis for the Detection of Invasive Fungal InfectionsRecruitingNCT06537726
• Effect of Photodynamic Therapy on Skin Microbiome. Single Center Study (PHOMIC-III)RecruitingNCT05676801Early Phase 1
• Characterization of Acute and Recent HIV-1 Infections in Zurich.RecruitingNCT00537966
• Effect of Photodynamic Therapy on Skin Microbiome. Single Center Study (PHOMIC-II)CompletedNCT04618276Not applicableResults posted
• Effect of Photodynamic Treatment on Skin Microbiome. Single Center StudyCompletedNCT04067843Not applicableResults posted
• Effect of Vancomycin After Catheter ReplacementStatus unknownNCT04856878Phase 4
• Interaction Between Non-typhoid Salmonella, Host Microbiota, and Immune System During Acute Infection and RemissionStatus unknownNCT03494101
• Modular Prevention Bundle for Non-ventilator-associated Hospital-acquired Pneumonia (nvHAP)TerminatedNCT03361085Not applicable
• Early Simplified: A Trial to Compare the Efficacy of Standard of Care Combination Antiretroviral Therapy With a Simplified Dolutegravir Monotherapy in Patients With a Primary HIV-1 InfectionStatus unknownNCT02551523Phase 2
• Vascular Graft InfectionsStatus unknownNCT01821664